REACTION from industry players to the significantly broadened scope of the Competition Commission’s market inquiry into the private healthcare sector was mostly positive when the final terms of reference were published on Friday. The final terms of reference adopted a far more holistic approach to the inquiry — set to start on January 6 — including looking at the inclusion of possible cost drivers such as pharmaceutical manufacturers, medical equipment, and the...
↧